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occlusion distal aorta-bilateral common iliac artery oc-
clusion. Patent distal external iliac/common femoral.
Technical Description: Left brachial access with
miro-puncture. 4 Fr. Sheath, pig tail catheter inserted to
abdominal aorta. Arteriogram showed distal aortic oc-
clusion extending to bilateral common iliac arteries with
reconstitution of external iliac. Under road mapping
sheath placed bilateral common femoral arteries. Right
CFA 5 Fr. Sheath, left CFA 6 Fr. Sheath. Selective
arteriogram through right sheath, showed more exten-
sive disease of right iliac and proximal external iliac artery
compared to the left side.Using a .035 hydrophilic wire
with a 4 Fr. Vertebral catheter used to cross right iliac
occlusion. Patent aortic distal lumen entered using wire
and catheter techniques. Left side, same technique used
cross common iliac artery occlusion, but aortic true
lumen could not be entered. .035 wire exchanged for
.014 wire. Pioneer Catheter (Re-entry device with IVUS
tip) inserted through left Sheath to reconstitution point.
Using IVUS, true lumen was identified with blood flow
on top. Needle from Pioneer catheter advanced, under
fluoroscopy, .014 wire passed into aorta. By measuring
depth of penetration on IVUS, needle length can be
adjusted on the Pioneer to penetrate through occlusion.
Needle retracted and Pioneer removed. A .035 catheter
inserted over .014 wire and wire exchanged for .035
wire. Patient given IV heparin and bilateral iliac angio-
plasty/ stenting performed. Stenting done using self-
expandable stents. no pressure gradient, Patient toler-
ated procedure without complications, discharge next
day. Office follow up, had palpable bilateral femoral
pulses with ABIs of .80 and .90. Her pain, completely
resolved.
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Preoperative Vein Mapping Reduces Major Surgical
Site Infections (SSI) and Readmissions in Infrainguinal
Bypass Surgery: Results of a Prospective Randomized
Trial
Klaus Linni, Nina Mader, Manuela Aspalter, Enzo But-
turini, Ara Ugurluoglu, Wolfgang Hitzl, Thomas J. Hol-
zenbein. Department of Vascular and Endovascular Sur-
gery, PMU Salzburg, Salzburg, Austria
Objectives: Although duplex vein mapping (DVM) of
the greater saphenous vein (GSV) is common practice,
there is no level-1 evidence for its application. The aim of
our prospective randomized trial was to study the impact of
preoperative DVM in infrainguinal bypass surgery.
Methods: Consecutive patients undergoing primary
bypass were prospectively randomized for DVM of the
GSV (Group A) or not (Group B) before surgery. SVS
reporting standards were applied.
Results: From 12/2009 to 12/2010 103 patients were
enrolled into the study. Group A (n 51) underwent DVM
of the GSV, Group B (n  52) did not. There was no
statistically significant difference between both groups regard-
ing age (A: 72.8 vs B: 71.1), gender (females: A: 29.4% vs B:
34.6%), cardiovascular risk factors, body mass index (A: 25.9
vs B: 26.1), bypass anatomy and runoff. Both groups were
equal regarding operative time (A: 151.4 min. vs B: 151.1
min), incisional length (A: 39.4cm vs B: 39.9cm), secondary
bypass patency at 30 days (A: 96.1% vs B: 96.2%, p n.s.). In
Group B there were 6 intraoperative changes of the operative
plan vs none in Group A (p 0.014), always due to conduit
issues. Median postoperative length of stay was longer in
Group B as compared to Group A (p  n.s.). SSI were
classified according to literature into minor (A: 23.5% vs B:
23.1% p n.s.) and major (A: 1.9% vs B: 21.2% p 0.004).
Readmissions due to SSI: Group A: 3.9% vs Group B: 19.2%
(p 0.038). In Group B two patients died following compli-
cations of SSI. Multivariate analysis identified preoperative
DVM as the only significant factor influencing the develop-
ment of major SSI (p0.038).
Conclusions: Routine DVM should be recommended
for infrainguinal bypass surgery. According to our study
preoperative DVM significantly avoids unnecessary surgical
exploration, development of major SSI, as well as frequency
of readmissions for SSI treatment.
Author Disclosures: M. Aspalter: Nothing to disclose; E.
Butturini: Nothing to disclose; W. Hitzl: Nothing to
disclose; T. J. Holzenbein: Nothing to disclose; K. Linni:
Nothing to disclose; N. Mader: Nothing to disclose; A.
Ugurluoglu: Nothing to disclose.
SS4.
Outcomes Following Heparin-Induced Thrombocyto-
penia in Patients with Heparin Bonded Vascular Grafts
Karthikeshwar Kasirajan. Emory University, Atlanta, GA
Objectives: Heparin-induced thrombocytopenia (HIT)
can result in a life or limb threatening condition. This study
was to evaluate the outcomes of patients with implanted
Gore propaten Vascular Grafts (W.L. Gore, Flagstaff, AZ)
and a subsequent suspicion of HIT.
Methods: All reports of suspected HIT following im-
plant of the propaten vascular graft reported to W.L. Gore
were analyzed.
Results: Overall, as of December 2010, there have been
24 cases of suspected HIT following implant for lower ex-
tremity revascularization (13), dialysis (5), extra-anatomical
(2), or other sites (4).HITwas confirmedby of ormore of the
these tests; ELISA, HIPA, SRA, or a HIT Panel. Among
patients with available data points, the mean pre-operative
heparin dose was 5071  1835 units and 4 patients had
post-operative heparin infusion. Mean pre-op platelet
count was 253,714  66,354 and dropped post-op to
56,769  38,745. Platelet counts returned to normal
following discontinuation of systemic heparin. Grafts
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remained implanted in 16 patients, explanted in 6, li-
gated in situ in 1, and the outcome was unknown for 1
patient. Among patients with grafts remaining in circu-
lation (16), 2 expired, 3 others required thrombectomy
for graft occlusion, and the other 11 patients had no
reported adverse events. Among the 7 patients with graft
removal/ligation, 3 required an amputation (2 major, 1
minor) and 2 different patients expired secondary to a
pulmonary embolism.
Conclusions: Analysis of the cases with implanted
propaten grafts reveals that theHIT appears to be related to
the systemic administration of heparin, as the platelet count
normalized following discontinuation of the systemic hep-
arin. Hence, based on current data, our recommendation
would be to tailor treatment to individual patients. Func-
tioning grafts in patients with or without thrombotic events
and return of platelet count to normal values may not
require grafts to be explanted.
Author Disclosures: K. Kasirajan: WL Gore,Research
Grants.
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Lifeline Resident Research Prize Paper
Decellularized Human Tissue Engineered Vessel as an
Arterial Conduit
Clay Quint1, Alan Dardik2, Laura Niklason2. 1Cleveland
Clinic, Shaker Heights, OH; 2Yale University, NewHaven,
CT
Objectives: The objectives of this study were to inves-
tigate the characteristics of decellularized human tissue
engineered vessels (TEV), and to evaluate the in vivo
performance as an arterial graft using a nude rat model.
Methods: Tissue engineered vessels were grown from
human smooth muscle cells that were seeded on a biode-
gradable scaffold using a biomimetic perfusion system. The
fresh and decellularized human TEV were compared using
histology and mechanical analysis. The nude rat model
consisted of implanting the decellularized TEV as an aortic
interpositional graft.
Results: In the decellularized human TEV, the colla-
gen matrix and mechanical strength were preserved in
comparison to fresh TEV. The human TEVs had a high
patency rate without evidence of rupture or aneurysm over
a six week period in a nude rat model. Histological analysis
showed a thin neointima with a confluent endothelium and
a subendothelial layer of smooth muscle cells on the ex-
planted TEV. Transmission electron microscopy on the
explanted tissue confirmed elastin formation in the
neointima.
Conclusions: The human decellularized tissue engi-
neered vessel demonstrated suitable mechanical properties
in vitro, and functioned as an arterial conduit in a small
diameter animal model. The host remodeling suggested
the engineered matrix had a positive effect to create a
regenerated vascular graft.
Author Disclosures: A. Dardik: Nothing to disclose; L.
Niklason: Humacyte, Ownership or Partnership; C.
Quint: Nothing to disclose.
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Predictors of Late Mortality Using Propensity Score
Matched Comparison of Open and Endovascular Re-
vascularization for Chronic Mesenteric Ischemia
Tiziano Tallarita, Gustavo S. Oderich, Peter Gloviczki,
Audra A. Duncan, Manju Kalra, Stephen Cha, Sanjay
Misra, Thomas Bower. Division of Vascular and Endovas-
cular Surgery, Mayo Clinic, Rochester, MN
Objectives: To evaluate predictors of late mortality
using propensity score matched comparison of open (OR)
or endovascular (ER) revascularization in patients treated
for chronic mesenteric ischemia (CMI).
Methods: The clinical data of 356 patients who had
revascularization for CMI was entered into a database
(1991-2010). Multivariate Cox regression analysis was
used to identify independent predictors of late death (30-
day). A propensity score matched comparison was used to
analyze survival estimates in patients treated with OR or
ER. Clinical risk stratification was reported using standard-
ized SVS score system.
Results: There were 336 patients followed for a me-
dian period of 96 months. Ninety-one patients died during
follow up from cardiac (n30), malignancy (n13), pul-
monary (n9), gastrointestinal (n6), sepsis (n2) or
renal causes (n2). Five patients (1.5%) died from late
complications of CMI; in 29 patients the cause of death was
not determined. Multivariate analysis identified age  80
years, dialysis, and home oxygen therapy as independent
predictors of death. Using a propensity score matched
comparison, survival was nearly identical for patients
Figure. Explant immunohistochemistry of decellularized human
tissue engineered vessel at 6 weeks stained with A) H&E, B)
SmoothMuscle -actin, C) von-Willibrand Factor, D) Elastin Van
Gieson. Scale bar  100 m
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